Report Detail
Global Biosimilar Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3042473 |
- 01 March, 2019 |
- Global |
- 124 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
Scope of the Report:
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.
First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.
Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.
Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.
Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.
At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
The worldwide market for Biosimilar Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Biosimilar Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Injection
Tablets
Other Types
Market Segment by Applications, can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug in 2017 and 2018.
Chapter 3, the Biosimilar Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Biosimilar Drug Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Injection
- 1.2.2 Tablets
- 1.2.3 Other Types
- 1.3 Market Analysis by Applications
- 1.3.1 Ankylosing Spondylitis
- 1.3.2 Tumor
- 1.3.3 Rheumatoid Arthrtis
- 1.3.4 Cardiovascular
- 1.3.5 Other Application
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Amgen
- 2.1.1 Business Overview
- 2.1.2 Biosimilar Drug Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Eli Lilly
- 2.2.1 Business Overview
- 2.2.2 Biosimilar Drug Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Novartis
- 2.3.1 Business Overview
- 2.3.2 Biosimilar Drug Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 CP Guojian Pharma
- 2.4.1 Business Overview
- 2.4.2 Biosimilar Drug Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Biotech Pharma
- 2.5.1 Business Overview
- 2.5.2 Biosimilar Drug Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biosimilar Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Biosimilar Drug Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Biosimilar Drug Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Biosimilar Drug Manufacturer Market Share in 2018
- 3.3.2 Top 6 Biosimilar Drug Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Biosimilar Drug Market Analysis by Regions
- 4.1 Global Biosimilar Drug Sales, Revenue and Market Share by Regions
- 4.1.1 Global Biosimilar Drug Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Biosimilar Drug Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Biosimilar Drug Sales and Growth Rate (2014-2019)
- 4.3 Europe Biosimilar Drug Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Biosimilar Drug Sales and Growth Rate (2014-2019)
- 4.5 South America Biosimilar Drug Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Biosimilar Drug Sales and Growth Rate (2014-2019)
5 North America Biosimilar Drug by Country
- 5.1 North America Biosimilar Drug Sales, Revenue and Market Share by Country
- 5.1.1 North America Biosimilar Drug Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Biosimilar Drug Revenue and Market Share by Country (2014-2019)
- 5.2 United States Biosimilar Drug Sales and Growth Rate (2014-2019)
- 5.3 Canada Biosimilar Drug Sales and Growth Rate (2014-2019)
- 5.4 Mexico Biosimilar Drug Sales and Growth Rate (2014-2019)
6 Europe Biosimilar Drug by Country
- 6.1 Europe Biosimilar Drug Sales, Revenue and Market Share by Country
- 6.1.1 Europe Biosimilar Drug Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Biosimilar Drug Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Biosimilar Drug Sales and Growth Rate (2014-2019)
- 6.3 UK Biosimilar Drug Sales and Growth Rate (2014-2019)
- 6.4 France Biosimilar Drug Sales and Growth Rate (2014-2019)
- 6.5 Russia Biosimilar Drug Sales and Growth Rate (2014-2019)
- 6.6 Italy Biosimilar Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Biosimilar Drug by Country
- 7.1 Asia-Pacific Biosimilar Drug Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Biosimilar Drug Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Biosimilar Drug Revenue and Market Share by Country (2014-2019)
- 7.2 China Biosimilar Drug Sales and Growth Rate (2014-2019)
- 7.3 Japan Biosimilar Drug Sales and Growth Rate (2014-2019)
- 7.4 Korea Biosimilar Drug Sales and Growth Rate (2014-2019)
- 7.5 India Biosimilar Drug Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Biosimilar Drug Sales and Growth Rate (2014-2019)
8 South America Biosimilar Drug by Country
- 8.1 South America Biosimilar Drug Sales, Revenue and Market Share by Country
- 8.1.1 South America Biosimilar Drug Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Biosimilar Drug Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Biosimilar Drug Sales and Growth Rate (2014-2019)
- 8.3 Argentina Biosimilar Drug Sales and Growth Rate (2014-2019)
- 8.4 Colombia Biosimilar Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Biosimilar Drug by Countries
- 9.1 Middle East and Africa Biosimilar Drug Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Biosimilar Drug Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Biosimilar Drug Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Biosimilar Drug Sales and Growth Rate (2014-2019)
- 9.3 Turkey Biosimilar Drug Sales and Growth Rate (2014-2019)
- 9.4 Egypt Biosimilar Drug Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Biosimilar Drug Sales and Growth Rate (2014-2019)
- 9.6 South Africa Biosimilar Drug Sales and Growth Rate (2014-2019)
10 Global Biosimilar Drug Market Segment by Type
- 10.1 Global Biosimilar Drug Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Biosimilar Drug Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Biosimilar Drug Revenue and Market Share by Type (2014-2019)
- 10.2 Injection Sales Growth and Price
- 10.2.1 Global Injection Sales Growth (2014-2019)
- 10.2.2 Global Injection Price (2014-2019)
- 10.3 Tablets Sales Growth and Price
- 10.3.1 Global Tablets Sales Growth (2014-2019)
- 10.3.2 Global Tablets Price (2014-2019)
- 10.4 Other Types Sales Growth and Price
- 10.4.1 Global Other Types Sales Growth (2014-2019)
- 10.4.2 Global Other Types Price (2014-2019)
11 Global Biosimilar Drug Market Segment by Application
- 11.1 Global Biosimilar Drug Sales Market Share by Application (2014-2019)
- 11.2 Ankylosing Spondylitis Sales Growth (2014-2019)
- 11.3 Tumor Sales Growth (2014-2019)
- 11.4 Rheumatoid Arthrtis Sales Growth (2014-2019)
- 11.5 Cardiovascular Sales Growth (2014-2019)
- 11.6 Other Application Sales Growth (2014-2019)
12 Biosimilar Drug Market Forecast (2019-2024)
- 12.1 Global Biosimilar Drug Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Biosimilar Drug Market Forecast by Regions (2019-2024)
- 12.2.1 North America Biosimilar Drug Market Forecast (2019-2024)
- 12.2.2 Europe Biosimilar Drug Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Biosimilar Drug Market Forecast (2019-2024)
- 12.2.4 South America Biosimilar Drug Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Biosimilar Drug Market Forecast (2019-2024)
- 12.3 Biosimilar Drug Market Forecast by Type (2019-2024)
- 12.3.1 Global Biosimilar Drug Sales Forecast by Type (2019-2024)
- 12.3.2 Global Biosimilar Drug Market Share Forecast by Type (2019-2024)
- 12.4 Biosimilar Drug Market Forecast by Application (2019-2024)
- 12.4.1 Global Biosimilar Drug Sales Forecast by Application (2019-2024)
- 12.4.2 Global Biosimilar Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Biosimilar Drug . Industry analysis & Market Report on Biosimilar Drug is a syndicated market report, published as Global Biosimilar Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Biosimilar Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
